€109.55
1.53% day before yesterday
L&S, Jul 05, 10:53 pm CET
ISIN
CH1216478797
Symbol
DSFIR
Index
AEX
Sector
Industry

DSM-Firmenich Target price 2024 - Analyst rating & recommendation

DSM-Firmenich Classifications & Recommendation:

Buy
77%
Hold
18%
Sell
5%

DSM-Firmenich Price Target

Target Price €120.91
Price €107.55
Potential
Number of Estimates 20
20 Analysts have issued a price target DSM-Firmenich 2025 . The average DSM-Firmenich target price is €120.91. This is higher than the current stock price. The highest price target is
€158.00 46.91%
register free of charge
, the lowest is .
A rating was issued by 22 analysts: 17 Analysts recommend DSM-Firmenich to buy, 4 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the DSM-Firmenich stock has an average upside potential 2025 of . Most analysts recommend the DSM-Firmenich stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Billion € 10.63 12.62
18.74%
EBITDA Margin 12.36% 15.66%
26.65%
Net Margin -7.04% 3.11%
144.18%

18 Analysts have issued a sales forecast DSM-Firmenich 2024 . The average DSM-Firmenich sales estimate is

€12.6b
Unlock
. This is
18.74% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€12.8b 20.08%
Unlock
, the lowest is
€12.4b 16.58%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €10.6b
2024
€12.6b 18.74%
Unlock
2025
€13.3b 5.20%
Unlock
2026
€13.7b 3.03%
Unlock
2027
€13.8b 1.07%
Unlock
2028
€14.8b 7.38%
Unlock

18 Analysts have issued an DSM-Firmenich EBITDA forecast 2024. The average DSM-Firmenich EBITDA estimate is

€2.0b
Unlock
. This is
40.47% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€2.1b 45.74%
Unlock
, the lowest is
€1.7b 22.83%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €1.3b
2024
€2.0b 50.41%
Unlock
2025
€2.3b 14.49%
Unlock
2026
€2.5b 8.52%
Unlock
2027
€2.6b 5.36%
Unlock
2028
€2.8b 7.91%
Unlock

EBITDA Margin

2023 12.36%
2024
15.66% 26.65%
Unlock
2025
17.05% 8.88%
Unlock
2026
17.95% 5.28%
Unlock
2027
18.72% 4.29%
Unlock
2028
18.81% 0.48%
Unlock

9 DSM-Firmenich Analysts have issued a net profit forecast 2024. The average DSM-Firmenich net profit estimate is

€393m
Unlock
. This is
149.36% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€623m 178.33%
Unlock
, the lowest is
€159m 120.00%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €-748m
2024
€393m 152.51%
Unlock
2025
€679m 72.86%
Unlock
2026
€846m 24.53%
Unlock
2027
€663m 21.58%
Unlock

Net Margin

2023 -7.04%
2024
3.11% 144.18%
Unlock
2025
5.11% 64.31%
Unlock
2026
6.18% 20.94%
Unlock
2027
4.80% 22.33%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share -2.82 1.48
152.48%
P/E 72.63
EV/Sales 2.45

9 Analysts have issued a DSM-Firmenich forecast for earnings per share. The average DSM-Firmenich <a href=/blog/eps>EPS is

€1.48
Unlock
. This is
149.33% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
€2.35 178.33%
Unlock
, the lowest is
€0.60 120.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €-2.82
2024
€1.48 152.48%
Unlock
2025
€2.56 72.97%
Unlock
2026
€3.19 24.61%
Unlock
2027
€2.50 21.63%
Unlock

P/E ratio

Current
2024
72.63 302.48%
Unlock
2025
42.02 42.15%
Unlock
2026
33.74 19.70%
Unlock
2027
43.03 27.53%
Unlock

Based on analysts' sales estimates for 2024, the DSM-Firmenich stock is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.91
2024
2.45 15.69%
Unlock
2025
2.33 4.95%
Unlock
2026
2.26 2.94%
Unlock
2027
2.24 1.06%
Unlock
2028
2.09 6.87%
Unlock

P/S ratio

Current
2024
2.26 15.79%
Unlock
2025
2.15 4.94%
Unlock
2026
2.09 2.94%
Unlock
2027
2.06 1.06%
Unlock
2028
1.92 6.87%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today